India Glycols (BOM:500201) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500201 India Glycols Ltd BOM:500201
66 GF Score
Price ₹1,189.20
GF Value ₹798.21
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is India Glycols Marketable Securities?

India Glycols BOM:500201 +3.90% 66 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:500201 with a GF Score™ of 66/100 and a GF Value™ of ₹798.21 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. India Glycols's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

India Glycols's annual Marketable Securities increased from Mar. 2024 (₹477 Mil) to Mar. 2025 (₹479 Mil) and increased from Mar. 2025 (₹479 Mil) to Mar. 2026 (₹571 Mil).

India Glycols  (BOM:500201) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

India Glycols Marketable Securities Related Terms

India Glycols Marketable Securities Historical Data

* Premium members only.

The historical data trend for India Glycols's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

India Glycols Marketable Securities Chart

India Glycols Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 389.36 456.99 476.85 478.55 570.60

India Glycols Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,350.70 0.00 570.60 0.00
BOM:500201
66GF Score
India Glycols Ltd BOM:500201
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

India Glycols Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
India Glycols (BOM:500201) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on India Glycols and its competitors.
Is India Glycols' Marketable Securities too high?
India Glycols' current Marketable Securities is ₹0 Mil. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Marketable Securities compare to DOW?
India Glycols' Marketable Securities of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on India Glycols and its competitors. India Glycols's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹798.21, compared to a current price of ₹1,189.20 — trading 49% above its estimated fair value. The current Marketable Securities is ₹0 Mil. India Glycols' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is India Glycols (BOM:500201) Overvalued in 2026?

Based on GuruFocus' analysis, India Glycols stock appears to be overvalued. The current stock price of ₹1,189.20 is trading 49% above its estimated GF Value™ of ₹798.21. GuruFocus considers India Glycols to be Significantly Overvalued.

Key valuation signals for BOM:500201:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹798.21 vs. price of ₹1,189.20 (49% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

India Glycols Business Description

Other Exchanges INDIAGLYCO:India
Address Plot No. 2B, Sector - 126, District Gautam Budh Nagar, Noida, UP, IND, 201304
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score

Get the complete analysis for BOM:500201

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,189.20
Price
₹798.21
GF Value